Company intelligence / Profile preview
Amarna Therapeutics
Leiden, Netherlandsamarnatherapeutics.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Amarna Therapeutics has developed a proprietary, non-immunogenic SV40-based gene delivery platform enabling repeated dosing and durable transgene expression. The company’s lead programs are in pre-clinical development for genetic disorders, autoimmune conditions, chronic inflammation, and dry AMD. Recent collaborations include a Eurostars grant with Phenocell to validate their approach in dry AMD using advanced retinal models. No clinical trial results have been reported yet.
- Therapeutic areas
- ImmunologyOphthalmologyRare Diseases
- Modalities
- Gene therapy (viral vector-based)Non-immunogenic viral vectors (SV40-derived)
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Phenocell SAS/Axol Bioscience – collaboration on dry AMD programNorthX Biologics – strategic manufacturing partnership for gene therapy development
Beyond the preview
Go deeper on Amarna Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amarna Therapeutics.